Fermenta Biotech Ltd - 506414 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Srikant N SharmaDesignation :- Company Secretary and Compliance Officer Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from Link Intime India Private Limited, Registrar and Transfer Agent about loss of share certificates today i.e. on April 5, 2022
Weekly Tactical Pick | Fermenta Biotech
Stock trading at close to long-term support levels Fermenta Biotech Ltd - 506414 - Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading, BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window, it is hereby notified that the 'Trading Window' (period for trading in Company's securities) will be closed with effect from April 01, 2022 till 48 hours after the declaration of financial results for the quarter and year ended March 31, 2022, as may be approved at the concerned Board Meeting. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's equity shares, either in their own name or in the name of their immediate relatives. The intimation regarding the Board Meeting date will be announced in due course. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for March 2022 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be attending the virtual investor conference hosted by Valorem Advisors on Monday, March 7, 2022 to discuss in detail about the ordinary course of business and industry which is already published under Company's investor presentations available on the website of the Company at www.fermentabiotech.com and BSE Limited at www.bseindia.com No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby enclose a copy of Investor Relations Presentation for February 2022 for your information. The said Investor Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We hereby enclose the Transcript of Earnings conference call held on Wednesday, February 16, 2022 regarding the financial performance of the Company for the quarter and nine months ended December 31, 2021 ['H2/Q3FY22']. The above Transcript shall also be uploaded on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Fermenta Biotech Ltd - 506414 - Publication Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2021
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated February 14, 2022, regarding declaration of Un-audited Financial Results for the quarter and nine months ended December 31, 2021, we are enclosing herewith photocopy of the newspaper publications published in Business Standard, Mumbai (English version) on page no. 11 and in Sakal, Mumbai (Marathi version) on page no. 11 dated February 15, 2022 for your reference and record.
Earnings Call for Q3FY22 of Fermenta Biotech
Conference Call with Fermenta Biotech Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.